Whitepaper

Biosimilars: Evidence From Europe
A look inside the European Union’s Biosimilar Market
Biosimilars Whitepaper | Biosimilars Evidence from Europe Whitepaper

More Whitepapers / Newsletters

Car-T Cell Therapy: A Journey From Challenges To Opportunities
Car-T Cell Therapy: A Journey...

With its innovative approach, chimeric antigen receptor T cell therapy created a new dawn in the age of cancer. Immunotherapy can be taken as a very powerful tool that can alter the immune system's pi...

Pompe Disease Newsletter
Pompe Disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also c...

Von Hippel-Lindau (VHL) Syndrome
Von Hippel-Lindau (VHL) Syndro...

An inherited disorder, Von Hippel-Lindau (VHL) syndrome is characterized by the formation of tumors and fluid-filled sacs (cysts) in up to ten different parts of the body including the brain, spine, e...

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As pe...

Hereditary ATTR (HATTR) Amyloidosis
Hereditary ATTR (HATTR) Amyloi...

Transthyretin Amyloidosis (ATTR) is a progressive build-up of abnormal deposits of amyloid protein in the body's organs and tissues. Hereditary ATTR (hATTR) amyloidosis is the most common form of ATTR...